Adarsh Bhimraj MD
Director, Infectious Diseases Fellowships & Education
Join to View Full Profile
6560 Fannin StSte 1540Houston, TX 77030
Phone+1 713-799-9997
Fax+1 713-799-2511
Dr. Bhimraj is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UPMC Medical EducationFellowship, Infectious Disease, 2006 - 2008
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 2003 - 2006
Gandhi Medical CollegeClass of 1999
Certifications & Licensure
TX State Medical License 2022 - 2025
OH State Medical License 2009 - 2023
PA State Medical License 2003 - 2009
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Retrospective Analysis of Clinical Features in Ventriculoperitoneal Shunt Infectionsin Adults Start of enrollment: 2007 Aug 01
Publications & Presentations
PubMed
- 1 citationsPharmacologic Treatment and Management of Coronavirus Disease 2019.Amy Hirsch Shumaker, Adarsh Bhimraj
Infectious Disease Clinics of North America. 2025-03-14 - 1 citationsPharmacokinetics of cefiderocol in a patient with carbapenem-resistant Acinetobacter baumannii ventriculitis: A case report.Natalie A Finch, Alejandro Granillo, Nazanin Pouya, Adarsh Bhimraj, William R Miller
Pharmacotherapy. 2025-01-01 - Beyond Words: Enhancing Clinical Guideline Comprehension With Icons.Isin Y Comba, John C O'Horo, Joel E Gordon, Yngve Falck-Ytter, Matthew M Moore
Open Forum Infectious Diseases. 2024-11-01
Press Mentions
A Crucial Group of Covid Drugs Has Stopped WorkingFebruary 8th, 2023- Anti-Inflammatory Agents May Have Role in COVID-19 PneumoniaOctober 25th, 2022
- Ivermectin: Still on a Losing Streak as COVID-19 TreatmentOctober 22nd, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
